Covid-19
Aulas presenciais e o risco de transmissão domiciliar de COVID-19 – “Embora as aulas presenciais sejam associadas a risco de transmissão domiciliar de Covid-19, este risco pode ser bastante controlado com medidas adequadas de prevenção implementadas na escola”
30 Abr, 2021 | 08:51hHousehold COVID-19 risk and in-person schooling – Science
Comunicado de Imprensa: In-Person Schooling with Inadequate Mitigation Measures Raises Household Member’s COVID-19 Risk – Johns Hopkins Bloomberg School of Public Health
Comentário no Twitter
After analyzing responses from the #COVID19 Symptom Survey, @JustinLessler et al. find support for the idea that in-person schooling increases COVID-19 risk to household members; but also evidence that common mitigation measures can reduce this risk. https://t.co/DFtCoN0FEE pic.twitter.com/gxt7nkhdMb
— Science Magazine (@ScienceMagazine) April 29, 2021
Estudo de coorte: Associação entre infecção materna por SARS-Cov-2 durante a gravidez e desfechos neonatais – “embora bebês nascidos de mães positivas para o vírus sejam mais propensos a partos prematuros, pouquíssimos foram infectados pela COVID-19”
30 Abr, 2021 | 08:48hAssociation of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes – JAMA
Comunicado de Imprensa: Low risk of infection in babies born to mothers with COVID-19 – Karolinska Institutet
Editorial: Understanding Risk for Newborns Born to SARS-CoV-2–Positive Mothers – JAMA
Comentário no Twitter
Maternal #SARSCoV2 infection in pregnancy was significantly associated with small increases in the absolute risk of respiratory disorders and some other neonatal morbidities https://t.co/ANkXkaxnwp
— JAMA (@JAMA_current) April 29, 2021
Opinião | O mundo poderia fazer muito mais para ajudar a Índia: os países não conseguem seguir sozinhos no enfrentamento da Covid-19
30 Abr, 2021 | 08:45hThe world could be doing much more to help India – Vox
Ver também: WHO provides update on India’s surging epidemic second wave and variant B.1.617 – Science Speaks: Global ID News E People Are Talking About A ‘Double Mutant’ Variant In India. What Does That Mean? – NPR E WHO says India COVID crisis could ‘happen anywhere’ – MedicalXpress E India’s COVID-19 Crisis Is Spiraling Out of Control. It Didn’t Have to Be This Way – TIME
“Conquista sem precedentes”: quem recebeu o primeiro bilhão de vacinas contra a COVID?
30 Abr, 2021 | 08:43h‘Unprecedented achievement’: who received the first billion COVID vaccinations? – Nature
“Brain fog” causada pela COVID-19 inspira busca por causas e tratamentos
30 Abr, 2021 | 08:41hCOVID-19 ‘brain fog’ inspires search for causes and treatments – Science (alguns artigos gratuitos por mês)
Opinião | Eliminação, e não redução, de SARS-CoV-2 traz melhores resultados para a saúde, a economia e as liberdades civis
30 Abr, 2021 | 08:39h
Contraponto: Comentário no Twitter (Fio – clique para saber mais)
Fantasy commentary letter in Lancet (not a peer reviewed study)!
It's an unreasonable proposition for most countries like the UK to achieve elimination + constraints of reality negates claimed economic and liberty benefits if attempted…
— Devan Sinha (@DevanSinha) April 29, 2021
Opinião | Uma ameaça pandêmica global deveria incentivar uma prevenção mais profunda
30 Abr, 2021 | 08:37hA global pandemic treaty should aim for deep prevention – The Lancet
Revisão: Coagulopatia associada a COVID-19 e agentes antitrombóticos – Em pacientes internados não críticos, anticoagulação em dose plena com heparina de baixo peso molecular pode melhorar os resultados clínicos. Em pacientes críticos, o mesmo tratamento não traz essa melhora, sendo recomendada a dose profilática
29 Abr, 2021 | 10:33hRelacionado: Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials E RCT: Intermediate-dose enoxaparin (1 mg/kg/d) not better than standard-dose prophylactic anticoagulation in patients with Covid-19 admitted to the intensive care unit
Comentário no Twitter
🆕💥💥State of the Art Review Article @TheLancetHaem by @MiddeldorpS
COVID-19-associated coagulopathy
Excellent explanation for the pathophysiology and great summary for the major RCTs and clinical guidelines https://t.co/NxP06KP2Hm pic.twitter.com/qHzyDsUZpt— Antibiotic Steward🆔🦠Bassam Ghanem (@ABsteward) April 28, 2021
Estudo inglês mostrou que uma dose de vacina contra a COVID-19 reduz até à metade a transmissão domiciliar – Esta proteção se une ao risco reduzido de uma pessoa vacinada desenvolver infecção sintomática, o qual varia de 60 a 65% após a primeira dose
29 Abr, 2021 | 10:31hComunicado de Imprensa: One dose of COVID-19 vaccine can cut household transmission by up to half – Public Health England
Estudo original (preprint): Impact of vaccination on household transmission of SARS-COV-2 in England – Public Health England
Comentários: Covid-19: One dose of vaccine cuts risk of passing on infection by as much as 50%, research shows – The BMJ E Covid: One dose of vaccine halves transmission – study – BBC
Estudo do CDC: Vacinas da Pfizer-BioNTech e Moderna reduzem o risco de hospitalização por Covid-19 em cerca de 64% após a primeira dose e 94% após a segunda dose entre adultos com 65 anos de idade ou mais
29 Abr, 2021 | 10:28hComentários: Pfizer/Moderna Vaccine Protection: 64% at First Dose, 94% at Second – HealthDay E Pfizer and Moderna vaccines reduce Covid-19 hospitalization risk by 94% among older adults, CDC study says – CNN
Comentário no Twitter
New @CDCMMWR has good news: mRNA COVID-19 vaccines (Pfizer-BioNTech, Moderna) reduced the risk of #COVID19-related hospitalization by 94% among fully vaccinated people 65+. CDC recommends getting a COVID-19 vaccine to prevent severe COVID-19 illness: https://t.co/W4SFuV6wQp. pic.twitter.com/Jf4ph2rl4s
— CDC (@CDCgov) April 28, 2021